1. Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies
   Xue-Liang Zhou et al, 2017, Oncotarget CrossRef
2. Metformin and blood cancers
   Ademar Dantas Cunha Júnior et al, 2018, Clinics CrossRef
3. Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells
   Dongho Kim et al, 2021, Cancers CrossRef
4. Metformin Promotes Apoptosis but Suppresses Autophagy in Glucose-Deprived H4IIE Hepatocellular Carcinoma Cells
   Deok-Bae Park, 2015, Diabetes & Metabolism Journal CrossRef
5. Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis
   Michael E. Grossmann et al, 2015, Current Pharmacology Reports CrossRef
6. Risk-Reducing (Chemopreventive) Agents in Breast Cancer Prevention
   Naomi Gronich et al, 2016, Trends in Breast Cancer Prevention CrossRef
7. Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
   Xilan Yu et al, 2017, Oncotarget CrossRef
8. Epigenetic effects of metformin: From molecular mechanisms to clinical implications
   Stephanie Claire Bridgeman et al, 2018, Diabetes, Obesity and Metabolism CrossRef
9. Repurposing metformin for the treatment of gastrointestinal cancer
   Ademar Dantas Cunha Júnior et al, 2021, World Journal of Gastroenterology CrossRef
10. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes
    Pauline A. J. Vissers et al, 2015, Breast Cancer Research and Treatment CrossRef
11. Type 2 diabetes mellitus and cardiovascular risk; what the pharmacotherapy can change through the epigenetics
    Pavlina A. Andreeva–Gateva et al, 2020, Postgraduate Medicine CrossRef